QR-koodi

Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccine

Abstract Data on the immunopersistence of one- or two-dose regimens of HPV vaccine in women aged 18–45 remains scarce. During 5.5-year follow-up of a Phase 3 clinical trial of Cecolin® (ClinicalTrials.gov, NCT01735006), blood samples were collected at day 0, month 7 and annually thereafter for neutr...

Täydet tiedot

Tallennettuna:
Päätekijät: Mengjun Liao, Jiali Quan, Kongxin Zhu, Xiaowen Hu, Shudan Shen, Jianhua Xu, Chu Nie, Weizhuo Xu, Hexuan Jiang, Xianliang Wu, Yanqin Zhong, Yuhang Peng, Shihui Cai, Jie Chen, Chengzong Zhang, Bizhen Lin, Yingying Su, Shoujie Huang, Qi Chen, Ting Wu, Jun Zhang, Ningshao Xia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Portfolio 2025-12-01
Sarja:npj Vaccines
Linkit:https://doi.org/10.1038/s41541-025-01335-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia